Dr. Brandt is the co-founder of vivoPharm. He is a biochemist and cell biologist with over 15 years experience in research programs of experimental oncology. Furthermore, he has immense experience in in vivo pharmacology and anti-cancer drug profiling. He received his Licence (BSc in Biochemistry and Animal Physiology) in 1986, and his PhD (in Biochemistry) in 1991 from the Martin-Luther University of Halle-Wittenberg, Germany. Dr. Brandt was employed at research positions at the National Cancer Institute in Bethesda, MD, USA and at Schering AG, Germany. Since 1990, Dr. Brandt has been active in the field of preclinical oncology. He led the Tumour Biology program at Novartis Pharma AG, Switzerland and established several transgenic mouse lines developing tumours under the control of oncogenes. During Dr. Brandt's long career in the pharmaceutical industry he has acquired significant knowledge and expertise in leading business units and representation of services to the pre-clinical research market. Dr. Brandt is a member of the Scientific Advisory Board at Receptor Inc. in Toronto Canada
Back to Top
Mrs Sabine Brandt is a co-founder of vivoPharm. Her career, which has spanned close to 10 years, includes financial management, financial planning and sales in a variety of industry sectors such as insurance and banking. In these roles, Mrs Brandt has gained experience within various departments of the banking and financial markets in Germany. Mrs Brandt led in the establishment of new offices for some insurance companies which has brought her a high level of experience in accounting and sales.
Back to Top
Dr. Florian Wolf joined vivoPharm as Vice President Australia in 2012 after a more than 20 year career in the global biosciences and demopharmaceutical industry. He is a biochemist and molecular biologist with extensive experience in managing multinational innovation and technology teams with a strong focus on discovery and development of new drugs and new delivery systems, as well as preclinical and clinical research and efficacy testing. Florian received his scientific education at the Universities of Hamburg, Germany, and Chicago, USA and obtained his Ph.D.in Molecular Oncology in 1991. After his Post-doc at the Universite Louis Pasteur, during which he developed transgenic and knock-out mouse models for retinoid acid receptor mutations, he progressively developed his managerial career by working for several prestigious international brands and companies, with Beiersdorf, Bayer, Oriflame and Jurlique among them, and developed and launched dozens of new products and brands. Capitalising on his technical expertise and managerial skills Florian worked up to Board level and obtained extensive experience in multinational innovation management in Europe, the US, Asia and Australia. After founding and successfully operating Jurlique R&D Pty. Ltd. Florian serially founded and successfully ran Elouera International Pty. Ltd., a dermopharmaceutical start-up company, Elouera Professional Solutions Pty. Ltd., a boutique life-science consultancy, and became Principal Consultant of Chemical Search in Singapore and Adelaide before joining vivoPharm in Bundoora (Melbourne). He is a multi-award winning, internationally recognised and acclaimed serial entrepreneur, lead inventor on more than 340 patents and has published more than 80 posters and papers at international conferences and in peer-reviewed scientific journals.
